263888-58-0 Usage
Uses
Used in Pharmaceutical Industry:
ISOINDOLINE-5-CARBONITRILE is used as a building block for the synthesis of various pharmaceuticals due to its ability to participate in multiple synthetic reactions, making it a valuable component in drug development.
Used in Pesticide Industry:
ISOINDOLINE-5-CARBONITRILE is used as a key intermediate in the production of pesticides, contributing to the development of effective and targeted pest control solutions.
Used in Dye Industry:
ISOINDOLINE-5-CARBONITRILE is utilized as a starting material for the synthesis of dyes, playing a crucial role in the creation of a diverse range of colorants for various applications.
Used in Fine Chemicals Production:
ISOINDOLINE-5-CARBONITRILE is employed in the production of fine chemicals, where its unique properties and reactivity contribute to the synthesis of high-quality specialty chemicals.
Used in Organic Synthesis:
ISOINDOLINE-5-CARBONITRILE is used as a versatile intermediate in organic synthesis, enabling the creation of a wide array of chemical compounds for various industries and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 263888-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,8,8 and 8 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 263888-58:
(8*2)+(7*6)+(6*3)+(5*8)+(4*8)+(3*8)+(2*5)+(1*8)=190
190 % 10 = 0
So 263888-58-0 is a valid CAS Registry Number.
263888-58-0Relevant articles and documents
RHO KINASE INHIBITORS
-
Paragraph 0276; 0277, (2015/04/28)
The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2. The present invention includes pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier and/or diluents. The present invention includes compositions comprising a substantially pure compound of the invention and a pharmaceutically acceptable salt, steroisomer, or hydrate thereof: and a pharmaceutically acceptable excipient and/or diluents.
Design and synthesis of novel 2,3-dihydro-1H-isoindoles with high affinity and selectivity for the dopamine D3 receptor
Austin, Nigel E,Avenell, Kim Y,Boyfield, Izzy,Branch, Clive L,Hadley, Michael S,Jeffrey, Phillip,Johnson, Christopher N,Macdonald, Gregor J,Nash, David J,Riley, Graham J,Smith, Alexander B,Stemp, Geoffrey,Thewlis, Kevin M,Vong, Antonio K.K,Wood, Martyn D
, p. 685 - 688 (2007/10/03)
Starting from the tetrahydroisoquinoline SB-2770111, a novel series of 5-substituted-2,3-dihydro-1H-isoindoles has been designed. Subsequent optimisation resulted in identification of 19. which has high affinity for the dopamine D3 receptor (pKi 8.3) and ≥ 100-fold selectivity over other aminergic receptors. In rat studies 19 was brain penetrant with an excellent pharmacokinetic profile (oral bioavailability 77%. t1/2 5.2h).